Walleye Capital’s SeaStar Medical ICU Stock Holding History

Walleye Capital’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-719	Closed	-$1.85M	–	3385
2022 Q3	$1.85M	Hold	719	–	–	0.04%	612
2022 Q2	$1.83M	Sell	719 -13	-2%	-$33K	0.05%	390
2022 Q1	$1.85M	Hold	732	–	–	0.05%	400
2021 Q4	$1.84M	Buy	+732	New	+$1.83M	0.06%	351

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's ICU Position: Q4 2022 in Review

Walleye Capital sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 719 shares — an estimated $1.85M sold.

Walleye Capital first reported a position in ICU in Q4 2021 and held it in 4 quarters. The position peaked at $1.85M in Q1 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

Walleye Capital reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 719 SeaStar Medical shares in Q4 2022, an estimated $1.85M.
Walleye Capital first reported a position in SeaStar Medical in Q4 2021 and held it in 4 quarters.
Walleye Capital's SeaStar Medical position peaked at $1.85M in Q1 2022.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.